Health and Social Services

HB 357, titled the Alaska Heartbeat Act, prohibits abortions after a fetal heartbeat is detected, directly affecting individuals seeking abortions and healthcare providers performing them. The bill requires abortions to be conducted only by licensed physicians in approved facilities, with specific consent and notification rules for minors. It amends civil procedure rules to enable civil enforcement of these abortion restrictions, allowing lawsuits to challenge violations. The legislation cites medical findings that cardiac activity indicates a likelihood of live birth, framing the heartbeat as a key medical milestone for legal protection. This bill would restrict access to abortion services beyond the point of fetal heartbeat detection, impacting both providers and patients seeking care.

HB 270 requires healthcare providers (including pharmacists, doctors, and advanced practice nurses) to offer a prescription for an opioid overdose drug (like naloxone) when prescribing opioids under specific conditions. It applies directly to patients receiving opioid prescriptions that exceed a three-day supply, exceed 50 milligrams morphine equivalent daily, involve concurrent benzodiazepines, or involve a history of overdose or substance use disorder. The bill mandates this offer as a standard step in prescribing, aiming to increase access to life-saving overdose reversal medication. It does not require patients to accept the offer but ensures providers proactively discuss it during high-risk opioid prescriptions.

HB 225 allows pharmacists to dispense fluoride supplements without an individual prescription, provided they operate under a standing order approved under existing law (AS 17.20.087). This directly affects pharmacists and patients seeking fluoride supplements for dental health. The bill requires pharmacists to provide patient counseling on proper administration, storage, side effects, and risks of the supplements. It amends pharmacy practice regulations to clarify this dispensing authority while maintaining safety requirements. The bill does not address fluoride in public water systems, as referenced in the title but not detailed in the provided text.

HB 273 establishes rules for "direct health care agreements" between dental/primary care providers and patients, where patients pay a periodic fee for services instead of using traditional insurance. It requires agreements to detail services, fees, locations, and complaint procedures, while explicitly stating patients lose protections under standard health insurance laws (AS 21.07). The bill prohibits Medicaid-eligible patients (under AS 47.07/47.08) from using these agreements and allows providers to decline new patients if they can’t provide needed services or lack capacity. It also permits termination based solely on inability to provide required services. This affects dental/primary care providers and patients seeking fee-for-service arrangements outside insurance systems.

HB 342 requires Alaska's State Medical Board to create a standardized informed consent form for minors receiving sex-reassignment treatments or procedures. The form must include specific disclaimers, such as that the FDA hasn't approved puberty blockers or hormones for gender dysphoria, that other countries recommend psychotherapy first, and that these treatments carry risks like sterility, heart disease, and unknown brain development effects. It directly affects minors seeking gender-affirming care, their physicians, and the State Medical Board. The bill modifies medical licensing regulations to mandate this form before any such treatment, requiring it to be provided at every visit for at least one year. The bill is currently under review by the Health & Social Services committee.